Cipla Limited chart

Last update: 2022-06-03
Key statistics and financials
Revenue per share 269.80
Dividend & Yield5.00₹ (0.52%)
Beta 0.43
Market capitalization 796.21B
Operating cash flow 33.26B
ESG Scores 31.4

Company description

Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other dosage forms consists of injectables and biosimilars. Cipla Limited has collaboration with CSIR-Indian Institute of Chemical Technology for the development of medication for the treatment of COVID-19; partnership with Karwa Ltd. for the commercialization of antibody detection kits for COVID-19; partnership with the Premier Medical Corporation Private Limited for the commercialization of the rapid antigen test kits for COVID-19; licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.

Sector: Healthcare - Industry: Drug Manufacturers—General

Financial Ratios
Quick Ratio1.91
Working Capital0.26
Return On Equity0.12
Debt To Equity0.02
Fixed Asset Ratio0.08
Fixed Interest Cover32.92

Financial data

Financial Statements

Cashflow Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Change To Liabilities -1.53B 4.87B 2.03B 3.62B
Total Cashflows From Investing Activities -16.69B 1.04B -23.87B -18.72B
Net Borrowings -602.5M -17.6B -11.68B -10.98B
Total Cash From Financing Activities -3.49B -29.49B -13.3B -16B
Change To Operating Activities
Issuance Of Stock 1.2M 1.1M 500k 700k
Net Income 15.28B 15.47B 24.05B 25.17B
Change In Cash -3.45B 2.34B 509.1M -1.32B
Effect Of Exchange Rate -188.5M 103.5M 127.9M 134.5M
Total Cash From Operating Activities 16.91B 30.68B 37.55B 33.26B
Depreciation 10.57B 10.56B 9.64B 10.52B
Change To Account Receivables -10.15B 2.17B 4.23B 813.6M
Other Cashflows From Financing Activities -470.2M -6.25B -1.62B -981.8M
Change To Netincome 1.3B 489.9M -244.5M -653.4M
Capital Expenditures -3.6B -5.73B -6.3B -5.44B

Income Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Research Development
Income Before Tax 20.62B 21.31B 32.77B 34.8B
Net Income 15.28B 15.47B 24.05B 25.17B
Selling General Administrative 37.42B 38.69B 41.28B 35.3B
Gross Profit 103.95B 109.32B 116.16B 132.68B
Ebit 20.41B 21.2B 32.66B 35.01B
Operating Income 20.41B 21.2B 32.66B 35.01B
Interest Expense -1.64B -1.89B -1.53B -1.06B
Income Tax Expense 5.7B 6.31B 8.89B 9.34B
Total Revenue 163.23B 170.81B 191.22B 217.63B
Cost Of Revenue 59.29B 61.48B 75.06B 84.96B
Total Other Income ExpenseNet 207.1M 107.4M 117.6M -203.8M
Net Income From Continuing Ops 14.92B 15B 23.89B 25.47B
Net Income Applicable To Common Shares 15.28B 15.47B 24.05B 25.17B

Balance Sheet Statement 2019-03-31 2020-03-31 2021-03-31 2022-03-31
Total Liabilities 86.19B 76.05B 65.66B 59.84B
Total Stockholder Equity 150.12B 157.63B 183.27B 208.42B
Other Current Liabilities 8.07B 9.86B 11.34B 19.24B
Total Assets 239.63B 236.63B 251.52B 271.01B
Common Stock 1.61B 1.61B 1.61B 1.61B
Other Current Assets 12.41B 10.02B 10.37B 18.09B
Retained Earnings 133.94B 142.6B 166.82B
Treasury Stock -1.17B -2.61B -1.3B 206.8B
Cash 5.08B 7.42B 7.93B 19.28B
Total Current Liabilities 37.72B 43.93B 45.92B 49.13B
Other Stockholder Equity -1.17B -2.61B -1.3B 206.8B
Property, Plant, and Equipment 55.07B 56.73B 56.49B 56.09B
Total Current Assets 124.27B 117.04B 131.81B 147.11B
Net Tangible Assets 102.35B 109.29B 134.91B 160.01B
Net Receivables 43.99B 42.26B 36.19B 34.28B
Accounts Payable 19.48B 22.82B 20.67B 25.08B


Insider Transactions

Here are the insider transactions of stock shares related to Cipla Limited:

Filer Name Transaction Text Ownership Date Filer Relation Shares
Jain (Anusha Dinesh)Sale at price 13.62 per share.D2022-03-11Promoter2k
Chauhan (Jinesh)Other at price 0.03 per share.D2021-07-17UNREPORTED1.22k
Chawla (Chandru)Other at price 0.03 per share.D2021-07-17UNREPORTED23.96k
George (Jortin)Other at price 0.03 per share.D2021-07-17UNREPORTED1.89k
Ladage (Kirit D)Other at price 0.03 per share.D2021-07-17UNREPORTED2.66k
Medh (Nihar)Other at price 0.03 per share.D2021-07-17UNREPORTED1.83k
Mitra (Debasish)Other at price 0.03 per share.D2021-07-17UNREPORTED2.66k
Rangwala (Aliakbar)Other at price 0.03 per share.D2021-07-17UNREPORTED3.97k
Raut (Preethi)Other at price 0.03 per share.D2021-07-17UNREPORTED2.33k
Srinivas (P L)Other at price 0.03 per share.D2021-07-17UNREPORTED1.77k
Vij (Vikas)Other at price 0.03 per share.D2021-07-17UNREPORTED1.83k
Agarwal (Anand)Other at price 0.03 per share.D2021-06-16UNREPORTED1.46k
Bhanushali (Sanjay S)Other at price 0.03 per share.D2021-06-16UNREPORTED20.28k
Gangrade (Manish)Other at price 0.03 per share.D2021-06-16UNREPORTED1.6k
Gupta (Sunil)Other at price 0.03 per share.D2021-06-16UNREPORTED2.13k
Hiranandani (Sneha)Other at price 0.03 per share.D2021-06-16UNREPORTED2.66k
Luharuka (Ajay)Other at price 0.03 per share.D2021-06-16UNREPORTED2.13k
Malhotra (Geena V)Other at price 0.03 per share.D2021-06-16UNREPORTED51.17k
Mishra (Sanjay Kumar)Other at price 0.03 per share.D2021-06-16UNREPORTED2.41k
Mistry (Raju)Other at price 0.03 per share.D2021-06-16UNREPORTED13.31k
Samanta (Gautam)Other at price 0.03 per share.D2021-06-16UNREPORTED1.06k
Thange (Vijay Laxman)Other at price 0.03 per share.D2021-06-16UNREPORTED1.49k
Kalidasan (Kamalesh)Other at price 0.03 per share.D2021-05-19UNREPORTED1.89k
Kumar (A S)Other at price 0.03 per share.D2021-04-21UNREPORTED3.78k
Mitra (Debasish)Other at price 0.03 per share.D2021-03-22UNREPORTED2.83k
Karta (Anil Kumar)Sale at price 11.31 per share.D2021-02-19UNREPORTED4k
Purandare (Shrinivas)Sale at price 11.60 per share.D2021-02-05UNREPORTED22k
Jagdale (Kuber M)Other at price 0.03 per share.D2021-01-20UNREPORTED2.64k
Jeffery (Patsy)Other at price 0.03 per share.D2020-12-21UNREPORTED3.78k
Ramanath (M S)Other at price 0.03 per share.D2020-12-21UNREPORTED1.53k
Srinivas (P L)Other at price 0.03 per share.D2020-12-21UNREPORTED1.89k
ICICI Prudential Mutual FundD2020-12-18Institution- Corporation673.56k
Hiranandani (Sneha)Other at price 0.03 per share.D2020-11-08UNREPORTED2.83k
Jain (Dinesh Ramniranjan)Other at price 0.03 per share.D2020-11-08UNREPORTED22.67k
Vohra (Umang)Other at price 0.03 per share.D2020-11-08UNREPORTED75.06k
Srivastava (Abhay Kumar)Other at price 0.03 per share.D2020-10-14UNREPORTED6.02k
Upadhye (Kedar)Other at price 0.03 per share.D2020-10-14UNREPORTED21.71k
Chauhan (Jinesh)Sale at price 10.52 per share.D2020-09-30UNREPORTED1.75k
Deshpande (Kaustubh)Sale at price 10.01 per share.D2020-09-25UNREPORTED800
Deshpande (Kaustubh)Other at price 0.03 per share.D2020-09-15UNREPORTED945
Pathak (Ranjana)Sale at price 10.23 per share.D2020-08-21UNREPORTED3.5k
Radhakrishnan (S.)Sale at price 10.43 per share.D2020-08-14Director (Non-Executive)20k
Anil (Kunal Khanna)Other at price 0.03 per share.D2020-08-13UNREPORTED2.85k
Gorana (Sanjay)Other at price 0.03 per share.D2020-08-13UNREPORTED9.1k
Gupta (Sunil)Other at price 0.03 per share.D2020-08-13UNREPORTED3.16k
Jagdale (Kuber M)Sale at price 10.15 per share.D2020-08-13UNREPORTED4.7k
Purandare (Shrinivas)Other at price 0.03 per share.D2020-08-13UNREPORTED8.5k
Radhakrishnan (S.)Sale at price 10.56 per share.D2020-08-11Director (Non-Executive)10k
Jagdale (Kuber M)Sale at price 10.65 per share.D2020-08-10UNREPORTED1.23k
Mukherjee (Subroto)Sale at price 10.54 per share.D2020-08-10UNREPORTED1.15k
Chawla (Chandru)Other at price 0.03 per share.D2020-07-16UNREPORTED25.49k

Insider transaction explanations

Insider buying is the legal purchase of shares by a senior executive or director of a company. "Filer Name" corresponds to the name of the stock buyer or seller. "Transaction Text" describes the transaction. "Ownership" gives information about the transaction type. "Date" is the reported transaction date. "Filer Relation" gives the role of the insider in the company. "Shares" is the value of the transaction. You will find the complete description of the General Transaction Codes on the SEC dedicated page


Investment strategy backtesting

These are the result of three automatic investment systems applied to Cipla Limited. You will find the performance of an systematic investment system, a momentum strategy, and a buy the dip trading strategy.


Systematic investment results on Cipla Limited

Here is the result of two systematic investment strategies applied to Cipla Limited. The first strategy automatically buys the first day of the month, and the second strategy buys the fifteenth day of the month.

Systematic investment equity curve on Cipla Limited

The following chart shows the equity curve of the two systematic investment strategies applied to Cipla Limited:

Cipla Limited automated entries

The systematic investment strategy that buys the first day of the month would give a performance of 10.47% on the backtest period.

Performance at glance

Performance

10.47 %

Latent gain

278.25 ₹

Invested capital

2656.95 ₹

Annualized return

8.05 %
Build your Trading System
Automated Trading using Prorealtime ebook

Momentum strategy results on Cipla Limited

This is the result of two momentum investment strategies applied to Cipla Limited. The first strategy uses a momentum signal calculated on one quarter, and the second uses a momentum signal calculated on two quarters.

Momentum entry openings on Cipla Limited

The following chart shows all the entries opened by the momentum investment system on Cipla Limited:

Cipla Limited momentum entries
  • The first momentum investment strategy would give 7.61% of return on Cipla Limited. That represents 553.3₹ of latent gain with 7273.9₹ of employed capital.
  • The second momentum investment strategy would give 7.98% of return on Cipla Limited. That represents 506.2₹ of latent gain with 6342.6₹ of employed capital.
Performance at glance (1Q Momentum)

Performance

7.61 %

Latent gain

553.3 ₹

Invested capital

7273.9 ₹

Annualized return

-0.0 %
Performance at glance (2Q Momentum)

Performance

7.98 %

Latent gain

506.2 ₹

Invested capital

6342.6 ₹

Annualized return

9.73 %

Momentum equity curve on Cipla Limited

The following chart shows the equity curve of the two momentum strategies applied to Cipla Limited:

Cipla Limited momentum equity

Note: the dividends potentially given by Cipla Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cipla Limited

The following chart shows the employed capital evolution of the two momentum strategies on Cipla Limited since the beginning:

Cipla Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250₹, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000₹.


Buy the dip strategy result on Cipla Limited

Buy the dip entry openings on Cipla Limited

Cipla Limited

The performance achieved by the robo-advisor on Cipla Limited is 0%. That represents 0.0$ of latent gain with 0.0₹ of employed capital. The following chart shows Cipla Limited stock price with all the entries opened by the automated investment system.

Note: The blue line represents the weekly stock price of Cipla Limited, and the green triangles represent the entry openings. The artificall robo-advisor needs at least 100 weeks of trading history to work.

Performance at glance

Performance

0 %

Latent gain

0.0 ₹

Invested capital

0.0 ₹

Annualized return

-0.0 %

Equity curve of the strategy applied to Cipla Limited

The following chart shows the result of the investment strategy applied to Cipla Limited:

Cipla Limited

Note: the dividends potentially given by Cipla Limited are not integrated into the calculation of the equity curve neither the performance of the strategy. The integration of the dividends will be available soon.


Employed capital on Cipla Limited

The following chart shows the employed capital evolution since the beginning of the investment strategy on Cipla Limited:

Cipla Limited

Note: the algorithm buys for a maximum of 250$ per entry. If the stock price is greater than 250$, the system buys only one stock per entry. The investment system stops automatically when the financial exposure reaches 10000$.


Investment strategies comparison on Cipla Limited

In this section, I will compare the three previous investment strategies applied to Cipla Limited.

Equity curve comparison on Cipla Limited

The following chart shows the equity curve of the artificall advisor, the trend folowing and the automatic investment strategies:

Cipla Limited investment strategy comparison

Employed capital comparison on Cipla Limited

Cipla Limited investment comparison

Performance comparison on Cipla Limited

Strategy Latent Profit Growth Employed capital CAGR
Automatic investment 10.47% 278.25₹ 2656.95₹ 8.05%
Momentum 1 quarter 7.61% 553.3₹ 7273.9₹ 7.18%
Momentum 2 quarters 7.98% 506.2₹ 6342.6₹ 9.73%
Non-directional 0% 0.0₹ 0.0₹ -0.0%
Annualized return comparison

Automatic investment

8.05 %

Momentum 1Q

9.73 %

Momentum 2Q

9.73 %

Non-directional

-0.0 %

Correlated stocks

Here are the most positively and negatively correlated stocks with Cipla Limited:

Positive correlations

Most correlated stocks this year


Most correlated stocks last 3 months

Negative correlation

Most negatively correlated stocks this year


Most negatively correlated stocks last 3 months

Note: The algorithm computes the probability of correlation between Cipla Limited and the other stocks. There may be false positives or some missing correlated stocks. If the price of Cipla Limited does not vary for 36 weeks, the correlation calculation result will be wrong.


Company information

Company name Cipla Limited
Country India
City Mumbai
Address Cipla House
Phone 91 22 2482 6000
Website www.cipla.com
FullTime employees
Industry Drug Manufacturers—General
Sector Healthcare
Exchange XNSE
Ticker CIPLA.XNSE
Market

Cipla Limited ESG Scores

Environment scores

Environment ESG Factors Scores
Environment Score 1.5
Peer Environment Performance 1.929512195122
Environment Percentile unknown
Palm Oil no
Nuclear no
Fur Leather no
GMO no
Coal no
Pesticides no
Animal Testing yes

Social scores

Social ESG Factors Scores
Social Score 18.2
Peer Social Performance 14.486219512195
Social Percentile unknown
Highest Controversy 2
Peer Highest Controversy Performance 1.9036144578313
Adult no
Gambling no
Alcoholic no
Tobacco no
Catholic yes
Controversial Weapons no
Small Arms no
Military Contract no
Peer Count yes

Related Controversy: Customer IncidentsSociety & Community Incidents


Governance scores

Governance ESG Factors Scores
Governance Score 11.6
Peer Governance Performance 8.7974390243902
Governance Percentile unknown

ESG at glance
Total ESG Scores: 31.4
Environment Score: 1.5
Social Score: 18.2
Governance Score: 11.6

ESG Performance: OUT_PERF

Peer Group: Pharmaceuticals

Peer Esg Score Performance: 25.407710843373

Rating Year: 2022

Rating Month: 5

Max Age: 86400

Percentile: 67